Event Details

Who should attend?

This is an introductory course and therefore very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries.

Details

By attending the Valuation course, you will:
1. Know what determines the value of life science biotechs and emerging pharma companies.
2. Gain a thorough understanding of key valuation terms, concepts, tools & techniques.
3. Learn and practice how to:
- Use a model that assesses the soft factors of a biotech company prior to its valuation.
- Calculate the value of a biotech company.
- Calculate the value of a development compound with an excel tool you can take home and use for any other pharmaceutical product in development.
- Structure licensing deals between pharma and biotech, covering issues such as milestones and royalty payments.
4. Gain expert insight and advice from Patrik Frei who has assessed and valued numerous products and companies in the life sciences industry.

Contact

Annelies Swaan
annelies.swaan@celforpharma.com